Briefly explain the neurobiological basis for PTSD illness.

Briefly explain the neurobiological basis for PTSD illness.

Briefly explain the neurobiological basis for PTSD illness.

  • Briefly explain the neurobiological basis for PTSD illness.
  • Discuss the DSM-5-TR diagnostic criteria for PTSD and relate these criteria to the symptomology presented in the case study. Does the video case presentation provide sufficient information to derive a PTSD diagnosis? Justify your reasoning. Do you agree with the other diagnoses in the case presentation? Why or why not?
  • Discuss one other psychotherapy treatment option for the client in this case studyExplain whether your treatment option is considered a “gold standard treatment” from a clinical practice guideline perspective, and why using gold standard, evidence-based treatments from clinical practice guidelines is important for psychiatric-mental health nurse practitioners.

Support your Assignment with specific examples from this week’s media and at least three peer-reviewed, evidence-based sources. Explain why each of your supporting sources is considered scholarly. Attach the PDFs of your sources.

More information:

https://www.youtube.com/watch?v=RkSv_zPH-M4

To complete this Assignment, you must assess the client, but you are not required to submit a formal comprehensive client assessment.

To assess the client use: Wheeler, K. (Ed.). (2020). Psychotherapy for the advanced practice psychiatric nurse: A how-to guide for evidence-based practice (3rd ed.). Springer Publishing.

  • Chapter 3, “Assessment and Diagnosis”

Expert Answer and Explanation

Neurobiological Basis for PTSD illness

The occurrence of Post-traumatic stress disorder is enabled by both biological and psychological factors. To understand the neurobiological basis of the illness, it is crucial to understand how traumatic experiences can impact the brain’s structure ad and chemical balance. One of the aspects to consider when analyzing the brain is the hippocampus. This region’s primary responsibility is memory formation and consolidation (Al Jowf et al., 2023). For patients with PTSD, the hippocampus might show altered activity which affects the way the traumatic memories have been formed. Another focus area is the amygdala.

This part is crucial in regulating emotions which include anxiety and fear. When a person is suffering from PTSD the amygdala usually becomes hyperactive and leads to extreme fear responses and invasive memories. The prefrontal cortex can also affect individuals with PTSD because it is responsible for decision-making and emotional regulation (Al Jowf et al., 2023). When it is underactive, one cannot effectively manage their emotions or rationalize fear. It is also crucial to understand how social factors and genes can contribute to PTSD.

DSM-5-TR diagnostic criteria for PTSD

The DSM diagnostic criteria make it possible for two different doctors to come up with the same diagnosis. This is considered the industry standard and it helps in making more accurate diagnoses. One aspect of consideration in the diagnosis should be the exposure to a traumatic event. The event can cause serious injury or threaten serious injury, cause actual death, or threaten death among other traumatic experiences (Martin et al., 2021). The second aspect is intrusion symptoms as explained by Al Jowf et al. (2023). This can include recurrent distressing memories of the event, and emotional distress upon exposure to cues that can be associated with the traumatic event.

The third measure is avoidance symptoms such as inability to recall crucial details of the events, avoidance of external events that remind them of the traumatic events, and avoiding thoughts or feelings that can be linked to the event. The fourth determinant of diagnosis is the negative alternations in cognition and moods. This can include negative emotional states, different perceptions of the world such as perceiving it as dangerous, and having intrusive thoughts about what caused the traumatic events and their consequences.

When considering the case study, there was sufficient information to diagnose PTSD (Morganstein et al., 2021). On the first cluster, it is clear that Joe had been exposed to a traumatic accident where he was involved in a minor traffic accident and they were pursued home by the assailant. In cluster B, Joe had intrusive nightmares about the traumatic event and also had emotional distress from remembering the event.

On cluster C, Joe had tried to block out memories of the event and this explains why he was only remembering fragments of the event as he filled it up with the worst scenarios to expect. In cluster D, it is clear that Joe was in constant fear that something bad would happen to his father as he was still living in the experience. Additionally, he experienced separation anxiety as he did not want to be separated from his father. I therefore agree with the diagnosis given.

Gold Standard for Addressing the Case

The gold standard when treating children with PTSD is trauma-focused cognitive behavioral therapy. According to Thielemann et al. (2022), this involves teaching a child and their parents about trauma and explaining that the symptoms are common experiences of people experiencing trauma. This therapy method then focuses on ensuring that they help children learn how to deal with the symptoms by helping them understand their thoughts and how the thoughts affect what they do and their lives in general.  After making children understand their thought systems and how they work, the treatment focuses on helping children talk about the trauma.

It is possible that they might not be willing to talk about it, but the therapist should slowly help them open up as that is a part of the experience and is necessary for healing (Chipalo, 2021). After this, there can be a trauma narrative which is usually stories written by the therapist for the children that allows them to think more about the trauma in a calm and safe space. Through the narrative, the child understands that they are now safe and quits reliving the trauma.

References

Al Jowf, G. I., Ahmed, Z. T., Reijnders, R. A., de Nijs, L., & Eijssen, L. M. T. (2023). To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers. International Journal of Molecular Sciences, 24(6), 5238. https://doi.org/10.3390/ijms24065238

Chipalo, E. (2021). Is Trauma Focused-Cognitive Behavioral Therapy (TF-CBT) Effective in Reducing Trauma Symptoms among Traumatized Refugee Children? A Systematic Review. Journal of Child & Adolescent Trauma, 14(4). https://doi.org/10.1007/s40653-021-00370-0

Martin, A., Naunton, M., Kosari, S., Peterson, G., Thomas, J., & Christenson, J. K. (2021). Treatment Guidelines for PTSD: A Systematic Review. Journal of Clinical Medicine, 10(18), 4175. https://doi.org/10.3390/jcm10184175

Morganstein, J. C., Wynn, G. H., & West, J. C. (2021). Post-traumatic stress disorder: update on diagnosis and treatment. BJPsych Advances, 1–3. https://doi.org/10.1192/bja.2021.13

Thielemann, J. F. B., Kasparik, B., König, J., Unterhitzenberger, J., & Rosner, R. (2022). A systematic review and meta-analysis of trauma-focused cognitive behavioral therapy for children and adolescents. Child Abuse & Neglect, 134, 105899. https://doi.org/10.1016/j.chiabu.2022.105899

Briefly explain the neurobiological basis for PTSD illness.

Q&A: Neurobiological Basis for PTSD Illness

Q1. What is Post‑Traumatic Stress Disorder (PTSD) and why is its neurobiological basis important?
A1. PTSD is a psychiatric disorder that can develop after exposure to a traumatic event and is characterized by symptoms such as intrusive memories, avoidance of trauma-related stimuli, negative changes in mood/cognition, and hyperarousal. Research into its neurobiological basis is important because it helps explain why certain individuals develop lasting symptoms, which biological systems are involved (e.g., brain regions, neurochemical systems, neuroendocrine axes), and thus may inform more targeted prevention and treatment strategies. PubMed+2PubMed+2

Q2. What brain regions are most consistently implicated in PTSD neurobiology?
A2. Key brain regions include:

  • The Amygdala (central to fear processing and emotional memory)

  • The Hippocampus (important in memory formation, contextualizing trauma)

  • The Prefrontal Cortex (especially the medial and ventromedial PFC) which regulates responses and extinction of fear.
    Structural and functional abnormalities in these regions (e.g., reduced hippocampal volume; hyperactive amygdala; impaired prefrontal control) have been noted in PTSD studies. BNA+2Boston University+2

Q3. What are some of the neuroendocrine changes observed in PTSD?
A3. Some of the neuroendocrine alterations include:

  • Dysregulation of the Hypothalamic–Pituitary–Adrenal axis (HPA axis), with altered cortisol secretion and feedback. PubMed+2RCA Storage+2

  • Increased noradrenergic (adrenergic) system activation (e.g., in the locus coeruleus) contributing to hyperarousal and exaggerated threat responses. PubMed+1

  • Changes in immune/inflammatory markers (e.g., altered cytokine levels) and interactions between stress systems and immune function. RCA Storage

Q4. How might decreased hippocampal volume relate to PTSD development or severity?
A4. Studies show that people with PTSD tend to have smaller hippocampal volumes compared with controls, and this might relate to impaired contextual memory and difficulties with fear extinction (i.e., the ability to suppress or regulate fear responses). Some research suggests smaller hippocampal volume may even be a pre-existing vulnerability factor rather than only a consequence of trauma. Boston University+1

Q5. What is the role of the fear network and anxiety network in PTSD, and why is the distinction relevant?
A5. The “fear network” typically refers to brain circuits directly processing immediate threat (e.g., amygdala, hippocampus). The “anxiety network” involves responses to uncertain or unpredictable threat (e.g., bed nucleus of the stria terminalis – BNST). Recent research suggests that PTSD in veterans involves altered connectivity not only in the classic fear circuit but also in anxiety-circuits (BNST, amygdala, hippocampus, prefrontal cortex). Understanding the distinction matters because therapeutic strategies may need to address both predictable-threat (fear) and unpredictable-threat (anxiety) processing. ISTSS

Q6. Why is it challenging to determine whether neurobiological changes are causes or effects of PTSD?
A6. Several issues make this challenging:

  • Many studies are cross-sectional (at one time point) rather than longitudinal, making it hard to know if brain changes preceded the trauma or resulted from it.

  • Trauma exposure itself may change biology, and likewise, pre-existing vulnerabilities (genetic, developmental) may predispose someone to PTSD. PubMed+1

  • Individual variation (e.g., sex, age, resilience factors, prior exposures) adds complexity to attributing causality.

Q7. What implications do neurobiological findings have for nursing practice or clinical treatment of PTSD?
A7. For nurses and other clinicians:

  • Understanding the underlying biology may improve assessment (e.g., recognizing physiological hyperarousal, neuroendocrine dysregulation) and patient education. PubMed

  • Treatment plans may integrate biologically-informed interventions (e.g., medications targeting HPA or noradrenergic systems, alongside psychotherapy) and may consider adjunctive therapies based on neurobiology (e.g., mindfulness, neuromodulation).

  • Awareness of vulnerabilities and resilience factors may guide prevention strategies, trauma-informed care, and early intervention.

Q8. What are some of the gaps or future directions in research on the neurobiology of PTSD?
A8. Some identified gaps/future directions include:

  • Better longitudinal studies to track neurobiological changes over time (pre-trauma to post-trauma).

  • Identification and validation of biomarkers for risk, resilience, and treatment response.

  • Translating neurobiological insights into novel therapies (e.g., neuromodulation, brain-network-specific interventions). PubMed+1

  • Improved understanding of individual differences (genetics, sex, developmental trauma) and how they influence neurobiology and treatment outcomes.

Quote

QUICK QUOTE

Approximately 250 words

USD $10.99

custom essy

Order an essay from experts and get an A+

Copyright © 2025 AcademicResearchBureau.com. All rights reserved

Disclaimer: All the papers written by AcademicResearchBureau.com are to be used for reference purposes only.